Acetylation is indispensable for p53 activation.

Modes of p53 regulation. Cell (2009) 9.31

Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature (2011) 5.20

Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell (2012) 4.96

p53 polymorphisms: cancer implications. Nat Rev Cancer (2009) 3.33

How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer (2008) 3.17

Transcriptional regulation by p53. Cold Spring Harb Perspect Biol (2010) 3.16

The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol (2010) 3.08

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell (2012) 2.96

G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem (2010) 2.64

p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med (2010) 2.54

Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell (2010) 2.40

Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol (2009) 2.34

Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol Cell (2009) 2.32

The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev (2010) 2.27

Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol Cell (2011) 1.87

The multiple levels of regulation by p53 ubiquitination. Cell Death Differ (2010) 1.87

Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol (2009) 1.80

Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res (2011) 1.77

Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell (2010) 1.75

SnapShot: p53 posttranslational modifications. Cell (2008) 1.75

SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell (2014) 1.73

The impact of acetylation and deacetylation on the p53 pathway. Protein Cell (2011) 1.66

The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci (2009) 1.64

p53-based cancer therapy. Cold Spring Harb Perspect Biol (2010) 1.62

Division and apoptosis of E2f-deficient retinal progenitors. Nature (2009) 1.55

Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing. Cell (2016) 1.55

p53 regulation by ubiquitin. FEBS Lett (2011) 1.51

Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci U S A (2009) 1.50

SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta (2010) 1.46

Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther (2010) 1.45

Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J (2009) 1.45

KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol (2009) 1.43

Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J (2009) 1.40

Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci U S A (2010) 1.39

The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol (2010) 1.35

Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med (2010) 1.35

Molecular characterization of propionyllysines in non-histone proteins. Mol Cell Proteomics (2008) 1.33

Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol (2012) 1.30

Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci U S A (2010) 1.30

SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60. J Biol Chem (2010) 1.30

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect. Invest New Drugs (2010) 1.27

The regulation of the p53-mediated stress response by MDM2 and MDM4. Cold Spring Harb Perspect Biol (2010) 1.23

Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr Opin Immunol (2010) 1.23

Regulation of SIRT1 activity by genotoxic stress. Genes Dev (2012) 1.22

Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. Biochemistry (2010) 1.21

Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res (2012) 1.20

MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A (2013) 1.19

Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene (2012) 1.19

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med (2012) 1.18

A neuroprotective phase precedes striatal degeneration upon nucleolar stress. Cell Death Differ (2013) 1.16

Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration. Proc Natl Acad Sci U S A (2011) 1.16

The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol (2010) 1.14

Epigenetic responses to environmental change and their evolutionary implications. Philos Trans R Soc Lond B Biol Sci (2009) 1.14

Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest (2013) 1.14

In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models. Carcinogenesis (2010) 1.14

Multiple transcription factor families regulate axon growth and regeneration. Dev Neurobiol (2011) 1.13

Lysine 88 acetylation negatively regulates ornithine carbamoyltransferase activity in response to nutrient signals. J Biol Chem (2009) 1.13

Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. Proc Natl Acad Sci U S A (2012) 1.12

Homozygous disruption of the Tip60 gene causes early embryonic lethality. Dev Dyn (2009) 1.12

RNA content in the nucleolus alters p53 acetylation via MYBBP1A. EMBO J (2011) 1.11

The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4-Not complex contribute to the prevention of cell death and senescence. Mol Biol Cell (2011) 1.11

Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis. Mol Cancer Res (2011) 1.10

p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival. Mol Cell Biol (2011) 1.08

Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br J Pharmacol (2014) 1.07

Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl. Cancer Res (2010) 1.06

Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ Res (2014) 1.06

Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death. Sci Signal (2013) 1.06

New insights into p53 activation. Cell Res (2010) 1.06

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1. Br J Cancer (2013) 1.06

p53 Oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem (2008) 1.06

Abl interconnects oncogenic Met and p53 core pathways in cancer cells. Cell Death Differ (2011) 1.05

Acetylation/deacetylation modulates the stability of DNA replication licensing factor Cdt1. J Biol Chem (2009) 1.05

Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging (Albany NY) (2009) 1.05

Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc Natl Acad Sci U S A (2011) 1.04

Keeping p53 in check: a high-stakes balancing act. Cell (2010) 1.04

Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element. EMBO J (2010) 1.04

Lysine-specific modifications of p53: a matter of life and death? Oncotarget (2013) 1.03

Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Oncotarget (2013) 1.03

Histone deacetylase 2 (HDAC2) regulates chromosome segregation and kinetochore function via H4K16 deacetylation during oocyte maturation in mouse. PLoS Genet (2013) 1.02

Glucose metabolism as a target of histone deacetylase inhibitors. Mol Endocrinol (2008) 1.01

DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget (2011) 1.01

Deacetylation of p53 induces autophagy by suppressing Bmf expression. J Cell Biol (2013) 1.01

Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opin Ther Targets (2012) 1.01

p53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseases. Neoplasia (2012) 1.01

A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature (2014) 1.01

SIRT1: Regulator of p53 Deacetylation. Genes Cancer (2013) 1.01

Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2. J Biol Chem (2010) 1.00

Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer (2012) 1.00

To be, or not to be: functional dilemma of p53 metabolic regulation. Curr Opin Oncol (2014) 1.00

Tuning the orchestra: transcriptional pathways controlling axon regeneration. Front Mol Neurosci (2012) 1.00

HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. J Biol Chem (2010) 1.00

Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway. Proc Natl Acad Sci U S A (2014) 0.99

Cabin1 restrains p53 activity on chromatin. Nat Struct Mol Biol (2009) 0.99

Inhibition of p53 DNA binding function by the MDM2 protein acidic domain. J Biol Chem (2011) 0.99

Familial dysautonomia model reveals Ikbkap deletion causes apoptosis of Pax3+ progenitors and peripheral neurons. Proc Natl Acad Sci U S A (2013) 0.98

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev (2014) 0.98

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Mol Med (2013) 0.98

Enterocyte-specific inactivation of SIRT1 reduces tumor load in the APC(+/min) mouse model. PLoS One (2013) 0.98

A critical role for noncoding 5S rRNA in regulating Mdmx stability. Mol Cell (2011) 0.98

Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases. Chem Rev (2014) 0.98

Translating the histone code. Science (2001) 56.77

WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72

Surfing the p53 network. Nature (2000) 35.36

The complex language of chromatin regulation during transcription. Nature (2007) 16.97

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 16.79

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97

Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05

p53 in health and disease. Nat Rev Mol Cell Biol (2007) 11.33

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (1995) 10.18

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68

A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67

The p53 pathway. J Pathol (1999) 6.79

Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell (2006) 5.64

p53 ubiquitination: Mdm2 and beyond. Mol Cell (2006) 5.57

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46

Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell (2006) 5.40

Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell (2004) 5.30

The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell (2003) 4.96

Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature (2000) 4.93

Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell (2001) 4.73

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A (2006) 4.68

DBC1 is a negative regulator of SIRT1. Nature (2008) 4.66

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell (2005) 4.60

The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol (2003) 4.46

Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29

MDM2 inhibitors for cancer therapy. Trends Mol Med (2006) 3.88

Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell (2001) 3.74

hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell (2007) 3.56

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J (2001) 3.37

Regulation of p53 function and stability by phosphorylation. Mol Cell Biol (1999) 3.24

Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell (2007) 3.20

Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol (2000) 3.12

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A (2004) 3.06

Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J (1999) 3.00

Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol (2005) 2.72

Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem (2004) 2.46

The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci U S A (2005) 2.40

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell (2006) 2.32

Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev (2002) 2.26

Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol (2006) 2.21

The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell (2004) 2.16

Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo. Curr Protoc Cell Biol (2004) 1.98

DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene (1999) 1.96

ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer (2007) 1.94

Mdmx as an essential regulator of p53 activity. Biochem Biophys Res Commun (2005) 1.85

The central region of HDM2 provides a second binding site for p53. Proc Natl Acad Sci U S A (2006) 1.67

Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol (2002) 1.65

An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell (2007) 1.48

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. J Biol Chem (2005) 1.47

Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. J Biol Chem (2006) 1.28

Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem (2006) 1.26

Mutational analysis of the p53 core domain L1 loop. J Biol Chem (2006) 1.25

Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell (2006) 11.38

Modes of p53 regulation. Cell (2009) 9.31

Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89

Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature (2002) 7.71

Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell (2006) 5.64

p53 ubiquitination: Mdm2 and beyond. Mol Cell (2006) 5.57

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol (2003) 5.46

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35

SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell (2007) 5.30

Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell (2011) 5.27

Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell (2009) 5.26

Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science (2003) 5.23

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science (2013) 5.10

RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell (2006) 5.08

Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell (2005) 5.04

Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell (2012) 4.96

SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab (2008) 4.89

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell (2005) 4.60

Non-transcriptional control of DNA replication by c-Myc. Nature (2007) 4.55

Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol Cell Proteomics (2008) 4.36

Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell (2002) 4.33

Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29

FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab (2005) 4.14

A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell (2004) 4.05

Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J Biol Chem (2003) 3.90

Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science (2003) 3.59

JMJD6 is a histone arginine demethylase. Science (2007) 3.48

Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem (2002) 3.37

How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer (2008) 3.17

Non-invasive prenatal measurement of the fetal genome. Nature (2012) 3.11

Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol Cell Proteomics (2007) 3.09

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A (2004) 3.06

Parc: a cytoplasmic anchor for p53. Cell (2003) 3.06

Acetylation inactivates the transcriptional repressor BCL6. Nat Genet (2002) 3.00

Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell (2009) 2.99

CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature (2010) 2.88

Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol (2010) 2.87

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol (2006) 2.85

The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics (2011) 2.83

Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation. J Proteome Res (2007) 2.76

A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci U S A (2004) 2.74

Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol (2005) 2.72

Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69

A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol (2005) 2.64

Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med (2011) 2.64

Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ (2007) 2.60

SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem (2005) 2.59

Association between gaseous ambient air pollutants and adverse pregnancy outcomes in Vancouver, Canada. Environ Health Perspect (2003) 2.55

p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med (2010) 2.54

Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell (2012) 2.46

Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest (2004) 2.35

Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol (2006) 2.35

Nearly finished genomes produced using gel microdroplet culturing reveal substantial intraspecies genomic diversity within the human microbiome. Genome Res (2013) 2.29

Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra. J Proteome Res (2005) 2.27

SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell (2013) 2.17

Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15

Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction. Cell (2011) 2.10

Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood (2006) 2.06

An intimate collaboration between peroxisomes and lipid bodies. J Cell Biol (2006) 2.04

A comprehensive synthetic genetic interaction network governing yeast histone acetylation and deacetylation. Genes Dev (2008) 2.01

Microfluidics for flow cytometric analysis of cells and particles. Physiol Meas (2005) 2.00

Lysine succinylation and lysine malonylation in histones. Mol Cell Proteomics (2012) 1.95

Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem (2003) 1.92

Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol (2006) 1.91

WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells. Proc Natl Acad Sci U S A (2006) 1.90

Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol Cell (2011) 1.87

Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med (2007) 1.85

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics (2002) 1.85

SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest (2012) 1.82

Proteome-wide prediction of acetylation substrates. Proc Natl Acad Sci U S A (2009) 1.81

Comparison of time series and case-crossover analyses of air pollution and hospital admission data. Int J Epidemiol (2003) 1.79

Proteomic analysis of integral plasma membrane proteins. Anal Chem (2004) 1.78

Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol Microbiol (2008) 1.78

The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res Treat (2011) 1.76

SnapShot: p53 posttranslational modifications. Cell (2008) 1.75

Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell (2009) 1.72

Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature (2010) 1.71

Improving genome assemblies by sequencing PCR products with PacBio. Biotechniques (2012) 1.70

Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol (2005) 1.70

Computer-controlled microcirculatory support system for endothelial cell culture and shearing. Anal Chem (2005) 1.70

Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J Antimicrob Chemother (2006) 1.69

Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression. Mol Cell (2013) 1.67

HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell (2006) 1.67

The impact of acetylation and deacetylation on the p53 pathway. Protein Cell (2011) 1.66

Proteomics of human breast ductal carcinoma in situ. Cancer Res (2002) 1.62

Gender-related differences in the association between socioeconomic status and self-reported diabetes. Int J Epidemiol (2003) 1.61